Fujirebio Europe N.V.:企業の戦略的SWOT分析

GlobalDataが発行した調査報告書(GDME1575SA)
◆英語タイトル:Fujirebio Europe N.V. - Strategic SWOT Analysis Review
◆商品コード:GDME1575SA
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年1月19日
◆ページ数:29
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ベルギー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Fujirebio Europe N.V. – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Fujirebio Europe N.V. (Fujirebio Europe), a subsidiary of Fujirebio Inc, is a global healthcare company. It designs, develops and produces in vitro diagnostic (IVD) testing solutions and markets them worldwide. Its diagnostic products consist of Innotest products for ELISA; INNO-LIA products for autoimmune diseases; INNO-LiPA products for line probe assay; INNO-BIA products for bead-based multiparameter immunoassay, and Lumipulse products for chemiluminescent enzyme immunoassay (CLEIA) system. The company products find application in the treatment of infectious diseases, cancer, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bones.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 – About the Company 6
Fujirebio Europe N.V. – Key Facts 6
Fujirebio Europe N.V. – Key Employees 7
Fujirebio Europe N.V. – Major Products and Services 8
Fujirebio Europe N.V. – History 11
Fujirebio Europe N.V. – Company Statement 14
Fujirebio Europe N.V. – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 16
Fujirebio Europe N.V. – Business Description 16
Fujirebio Europe N.V. – Corporate Strategy 17
Fujirebio Europe N.V. – SWOT Analysis 18
SWOT Analysis – Overview 18
Fujirebio Europe N.V. – Strengths 18
Strength – Strategic Partnerships and Alliances 18
Strength – Commitment to Quality 18
Strength – Established Presence in Markets 18
Fujirebio Europe N.V. – Weaknesses 19
Weakness – Single Market Segment 19
Fujirebio Europe N.V. – Opportunities 20
Opportunity – Growing IVD Market 20
Opportunity – New Product Launches 20
Opportunity – Changing Demographics 20
Fujirebio Europe N.V. – Threats 21
Threat – Short Product Life Cycle 21
Threat – Stiff Competition 21
Threat – Stringent Regulations 21
Fujirebio Europe N.V. – Key Competitors 22
Section 3 – Company’s Lifesciences Financial Deals and Alliances 23
Fujirebio Europe N.V., Medical Equipment, Deals By Year, 2010 to YTD 2016 23
Fujirebio Europe N.V., Medical Equipment, Deals By Type, 2010 to YTD 2016 24
Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 25
Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 26
Fujirebio Europe N.V., Recent Deals Summary 27
Section 4 – Company’s Recent Developments 28
Mar 05, 2015: Fujirebio Europe Upgrades Its HPV Genotyping Panel With The Launch Of The Inno-Lipa HPV Genotyping Extra II Assay 28
Section 5 – Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Fujirebio Europe N.V., Key Facts 6
Fujirebio Europe N.V., Key Employees 7
Fujirebio Europe N.V., Major Products and Services 8
Fujirebio Europe N.V., History 11
Fujirebio Europe N.V., Subsidiaries 15
Fujirebio Europe N.V., Key Competitors 22
Fujirebio Europe N.V., Medical Equipment, Deals By Year, 2010 to YTD 2016 23
Fujirebio Europe N.V., Medical Equipment, Deals By Type, 2010 to YTD 2016 24
Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 25
Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 26
Fujirebio Europe N.V., Recent Deals Summary 27

List of Figures
Fujirebio Europe N.V., Medical Equipment, Deals By Year, 2010 to YTD 2016 23
Fujirebio Europe N.V., Medical Equipment, Deals by Type, 2010 to YTD 2016 24
Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 25
Fujirebio Europe N.V., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 26

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Fujirebio Europe N.V.:企業の戦略的SWOT分析(Fujirebio Europe N.V. - Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆